1. Akar N, Hasipek M, Akar E. Serum amyloid A1 and tumor necrosis
factor-alpha alleles in Turkish familial Mediterranean fever
patients with and without amyloidosis. Amyloid 2003; 10:12-16.
2. Ben-Chetrit E, Levy M. Familial Mediterranean Fever. Lancet
1998; 351: 659-667.
3. Ben-Chetrit E. Familial Mediterranean Fever (FMF) and renal
AAamyloidosis-phenotype-genotype correlations, treatment and
prognosis. J Nephrol 2003; 16: 431-438.
4. Ben-Cheritt E, Backenroth R. Amyloidosis induced, end stage renal
diseasein patients with familial Mediterranean fever is highly
associated with point mutations in the MEFV gene. Ann Rheum
Dis 2001; 60: 146-149.
5. Blum A, Sohar E. The diagnosis of amyloidosis.Ancillary procedures.
Lancet 1962; 1: 721-724.
6. Brik R, Shinawi M, Kepten I. Familial Mediterranean fever: clinical
and genetic characterization in a mixed pediatric population
of Jewish and Arab patients. Pediatrics 1999; 103: 70-76.
7. Cazeneuve C, Sarkisian T, Pecheux C. MEFV-gene analysis in
Armenian patients with Familial Mediterranean fever: diagnostic
value and unfavorable renal prognosis of the M694V homozygous
genotype-genetic and therapeutic implications. Am J Hum Genet
1999; 65:88-97.
8. Dagan T, Danon Y, Lotan R. Phenotype-genotype in FMF: Familial
Mediterranean Fever. The official book of 1 st International
Conference on FMF, September 1997; 239-245.
9. Duzova A, Bakkaloglu A, Besbas N. Role of A-SAA in monitoring
subclinical inflammation and in colchicine dosage in familial
Mediterranean fever. Clin Exp Rheumatol 2003; 21: 509-514.
10. Gershoni-Baruch R, Brik R, Shinawi M. The differential contribution
of MEFV mutant alleles to the clinical profile of familial
Mediterranean fever. Eur J Hum Genet 2002; 10: 145-149.
11. Gershoni-Baruch R, Brik R, Zacks N. The contribution of genotypes
at the MEFV and SAA1 loci to amyloidosis and disease
severity in patients with familial Mediterranean fever. Arthritis
Rheum 2003; 48: 1149-1155.
12. Goldfinger SE. Colchicine for familial Mediterranean fever. N
Engl J Med 1972; 287: 1302.
13. Korkmaz C, Ozdogan H, Kasapcopur O. Acute phase response in
familial Mediterranean fever. Ann Rheum Dis 2002; 61:79-81.
14. Lidar M, Yaqubov M, Zaks N. The prodrome: a prominent yet
overlooked pre-attack manifestation of familial Mediterranean
fever. J Rheumatol 2006; 33: 1089-1094.
15. Livneh A, Shtrasburg S, Langevitz P. Regression of nephrotic
syndrome in amyloidosis of familial Mediterranean fever following
colchicine treatment. Nephrol Dial Transplant 2000;
15:1713-1714.
16. Majeed HA, El-Shanti H, Al-Khateeb MS. Genotype/phenotype
correlations in Arab patients with familial Mediterranean fever.
Semin Arthritis Rheum 2002; 31:371-376.
17. Mansour I, Delague V, Cazeneuve C. Familial Meditarranean fever
in Lebanon: mutation spectrum, evidence cases in Maronites,
Greek Orthodoxes, Greek Catholics, Syriacs and Chiites and for
an association between amyloidosis and M694V and M691 mutations.
Eur J Hum Genet 2001; 9: 51-55.
18. Minetti EE, Minetti L. Multiple organ failure in a kidney transplant
patient receiving both colchine and cyclosporine. J Nephrol
2003; 16: 421-425.
19. Ozdogan H, Ar›soy N, Kasapcapur O, Sever L, Cal›skan S, Tuzuner
N, Mat C, Yaz›c› H. Vasculitis in familial Mediterranean fever.
J Rheumatol 1997; 24: 323-327.
20. Ozen S, Karaaslan Y, Ozdemir O. Prevalance of juvenile chronic
arthritis and familial Mediterranean fever in Turkey: a field study.
J Rheumatol 1998; 25: 2445-2449.
21. Pras E, Aksentijevich I, Gruberg L. Maping of a gene causing fa-
Renal involvement
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 72 • Say› / Number: 2 • Y›l/Year: 2009
- 73 -
milial Mediterranean fever to the short of chromosome 16. N
Engl J Med 1992; 326: 1507-1509.
22. Pras E, Livneh A, Balow JE. Clinical differences between north
African and Iraqi Jews with familial Mediterranean fever. Am J
Med Genet 1998; 75: 216-219.
23.Rubinger D, Friedlaender MM, Popovtzer MM. Amelioration of
familial Mediterranean fever during hemodialysis. N Engl J Med
1979; 301: 142-144.
24. Saatc› U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu
R, Arslan S. Familial Mediterranean fever in children: report of
a large series and discussion of the risk and prognostic factors of
amyloidosis. Eur J Pediatr 1997; 156: 619-623.
25. Said R, Hamzeh Y, Tarawneh M, el-Khateeb M, Abdeen M, Shaheen
A. Rapid progressive glomerulonephritis in patients with familial
Mediterranean fever. Am J Kidney Dis 1989; 14: 412-416.
26.Shonat M, Danon YL, Rotter JI. Familial Mediterranean fever:
Analysis of inheritance and current linkage data. Am J Med Genet
1992; 44: 183-188.
27. Shonat M, Livneeh A, Zemer D. Twin studies in familial Mediterranean
fever. Am J Med Genet 1992; 44: 179-186.
28. Sidi G, Shinar Y, Livneh A. Protracted febrile myalgia of familial
Mediterranean fever. Mutation analysis and clinical correlations.
Scand J Rheumatol 2000; 29: 174-176.
29. Sohar E, Gafni J, Pras M. Familial Mediterranean fever a survey
of 470 cases and review of the literature. Am J Med 1967; 43:
227-253.
30. Tekin M, Yalc›nkaya F, Cakar N. MEFV mutations in multiplex
families with familial Mediterranean fever. is a particular genotype
necessary for amyloidosis? Clin Genet 2000; 57: 430-434.
31. Tekin M, Yalc›nkaya F, Tumer N, Cakar N, Kocak H, Ozkaya N,
Gencgonul H. Familial Mediterranean fever- renal involvement
by diseases other than amyloid. Nephrol Dial Transplant 1999;
14: 475-479.
32.The International FMF Consortium. Ancient missense mutations
in a new member of the RoRet gene family are likely to cause familial
Mediterranean fever. Cell 1997; 90: 797-807.
33. The French FMF Consortium. Acandidate gene for familial Mediterranean
fever. Nat Genet 1997; 17: 25-31.
34. Tidow N, Chen X, Muller C. Hematopoietic- specific expression
of MEFV, the gene mutated in familial Mediterranean fever, and
subcellular localization of its corresponding protein, pyrin. Blood
2000; 95: 1451-1459.
35. Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in
amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol
1988; 6: 395-397.
36. Touitou I, Picot M-C, Domingo C. The MICA region determines
the first modifier locus in familial Mediterranean fever. Arthritis
Rheum 2001; 44: 163-169.
37. Turkmen A, Y›ld›z A, Erkoc R. Transplantation in renal amyloidosis.
Clin Transplant 1998; 12: 375-378.
38. Yalc›nkaya F, Tekin M, Cakar N. Familial Mediterranean fever
and systemic amyloidosis in untreated Turkish patients. Q J Med
2000; 93: 681-684.
39. Yalc›nkaya F, Tumer N. Glomerular lesions other than amyloidosis
in patients with familial Mediterranean fever. Nephrol Dial
Transplant 1999; 14: 21-23.
40. Y›ld›z A, Akkaya V, K›l›caslan R. Cardiac and intestinal amyloidosis
in a renal transplant recipient with familial Mediterranean
fever. J Nephrol 2001; 14: 125-127.
41. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term
colchicine treatment in children with familial Mediterranean fever.
Arthritis Rheum 1991; 34: 973-977.
42. Zemer D, Pras M, Sohar E. Colchicine in the prevention and treatment
of the amyloidosis of familial Mediterranean fever. N
Engl J Med 1986; 314: 2001-2005.
Thank you for copying data from http://www.arastirmax.com
